View Author
plaque study heart patient swets subs service ancestry disease participant african ancestry circulation event death university trial value european ancestry genome-wide table association european incident tranilast african research group health blood factor figure failure cohort mortality center individual placebo restenosi population service institute medicine incident hf marker downloaded incident heart failure treatment heart failure artery syndrome infarction result 10-6 robert p values department follow-up lotrafiban october chromosome analyses hospital genome-wide significance variant coll cardiol variation laboratory lesion atherosclerosi cardiology thrombosis protein genomic framingham heart study health study atherosclerotic risk factors technique point number vulnerability african-ancestry participants
7 Most Recent Publications
|
Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry : A prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium
(Article)
Smith, N.L. Felix, J.F. Lieb, W. Rivadeneira Ramirez, F. Bis, J.C. Folsom, A.R. Benjamin, E.J. Aulchenko, Y.S. Haritunians, T. Couper, D.J. Murabito, J. Wang, Y.A. Morrison, A.C. Stricker, B.H.Ch. Gottdiener, J.S. Chang, P.P. Wang, T.J. Rice, K. Hofman, A. Heckbert, S.R. Fox, E.R. O'Donnell, C.J. Uitterlinden, A.G. Demissie, S Rotter, J.I. Willerson, J.T. Levy, D. Duijn, C.M. van Psaty, B.M. Witteman, J.C.M. Boerwinkle, E. Vasan, R.S. Glazer, N.L. Loehr, L.R. Cupples, L.A. Dehghan, A. Lumley, T. Rosamond, W.D. |
2010-06-01
|
|
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: The cohorts for heart and aging research in genomic epidemiology consortium
(Article)
Morrison, A.C. Felix, J.F. Wang, T.J. Haritunians, T. Folsom, A.R. Rivadeneira Ramirez, F. Benjamin, E.J. Lumley, T. Couper, D.J. Stricker, B.H.Ch. Rice, K. Chang, P.P. Cupples, L.A. Hofman, A. Levy, D. Rotter, J.I. Fox, E.R. Uitterlinden, A.G. Psaty, B.M. Willerson, J.T. Tikka-Kleemola, P. Boerwinkle, E. Witteman, J.C.M. Glazer, N.L. Vasan, R.S. Smith, N.L. O'Donnell, C.J. Loehr, L.R. Dehghan, A. Demissie, S Bis, J.C. Rosamond, W.D. Aulchenko, Y.S. |
2010-06-01
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-14
|
|
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
(Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G. |
2003-10-07
|
|
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
(Article)
Topol, E.J. Easton, D. Granett, J.R. Shuaib, A. Koudstaal, P.J. Theroux, P. Werf, F.J.J. van de Sigmon, K.N. Pieper, K.S. Vallee, M. Willerson, J.T. Harrington, R.A. Amarenco, P. Califf, R.M. Graffagnino, C. Davis, S.M. Diener, H.C. Ferguson, J.J. Fitzgerald, D. |
2003-07-01
|
|
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial
(Article)
Holmes Jr, D.R. Granett, J.R. Davis, B.R. Poland, M. Zeiher, A.M. Willerson, J.T. King 3rd, S.B. Shapiro, L.M. Savage, M. Lablanche, J.M. Tcheng, J.E. Grip, L. Popma, J.J. Serruys, P.W.J.C. Fitzgerald, P.J. Fischman, D. Ferguson, J.J. Lincoff, A.M. Goldberg, S. Brinker, J.A. Chan, R. |
2002-01-01
|
|
Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty
(Article)
Serruys, P.W.J.C. Klein, W. Eichhorn, E. Willerson, J.T. Anderson, H.V. Khaja, F. Alexander, R.W. Baim, D.S. Melkert, R. Oene, J.C. van Gool, R. van Tijssen, J.G.P. Rutsch, W.R. Heyndrickx, G.R. Emanuelsson, H.U. Ball, S.G. Decoster, O. Schoeder, E. Liberman, H. |
1993-01-01
|
